WVE vs XBIT

Wave Life Sciences Ltd. vs XBiotech Inc. — Valuation Comparison 2026

WVE

Biotechnology
Wave Life Sciences Ltd.
Quality
6.7
out of 10
Value Trap
30
LOW
Price
$6.47
Last close
Models
9/13
Active
VS

XBIT

Biotechnology
XBiotech Inc.
Quality
4.7
out of 10
Value Trap
20
SAFE
Price
$2.44
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType WVE Fair ValueWVE Upside XBIT Fair ValueXBIT Upside
Bayesian DCF Intrinsic $3.25 -49.8% $2.56 +4.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $3.72 -42.5% $4.70 +92.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for WVE vs XBIT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

WVE vs XBIT — Which Stock Is More Undervalued?

WVE scores higher with a 6.7/10 quality rating vs XBIT's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Wave Life Sciences Ltd. (WVE) and XBiotech Inc. (XBIT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

WVE currently trades at $6.47 with a QOC of 6.7/10, while XBIT trades at $2.44 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).